← Back to Search

64Cu-SAR-bisPSMA for Prostate Cancer (COBRA Trial)

Phase 1 & 2

Waitlist Available

Research Sponsored by Clarity Pharmaceuticals Ltd

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 hours

Awards & highlights

COBRA Trial Summary

This trial is testing a new way to detect prostate cancer recurrence using PET/CT. They want to see if it is safe and accurate.

Eligible Conditions

Prostate Cancer Recurrence

COBRA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence and severity of 64Cu-SAR-bisPSMA Treatment-Emergent Adverse Events and Serious Adverse Events [Safety and Tolerability]

Participant-level correct detection rate

Region-level positive predictive value

COBRA Trial Design

1Treatment groups

Experimental Treatment

Group I: 64Cu-SAR-bisPSMAExperimental Treatment1 Intervention

Patients will receive a single administration of 200 megabecquerels (MBq) of 64Cu-SAR-bisPSMA.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

64Cu-SAR-bisPSMA

2022

Completed Phase 2

~90

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Clarity Pharmaceuticals LtdLead Sponsor

10 Previous Clinical Trials

687 Total Patients Enrolled

2 Trials studying Prostate Cancer

413 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In how many different medical institutions is this research project being conducted today?

"There are six clinical trial sites currently recruiting patients, including Genesis Care in Fort Myers, Carolina Urologic Research Center in Myrtle Beach, and GU Research Network in Omaha."

Answered by AI

What is the projected or ideal number of patients for this clinical trial?

"This study requires 50 willing and eligible participants. The specified inclusion criteria must be met in order to take part in the trial. Patients can go to Genesis Care in Fort Myers, Florida or Carolina Urologic Research Center in Myrtle Beach, South carolina to participate."

Answered by AI

Is it possible to join this research project currently?

"Yes, the information available on clinicaltrials.gov shows that this trial is recruiting patients. This study was first posted on April 11th, 2022 and updated October 11th, 2022. They are looking for 50 individuals to participate at 6 different sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)

2022. "64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05249127.